Literature DB >> 20346619

Cepstral analysis of voice in unilateral adductor vocal fold palsy.

Radish Kumar Balasubramanium1, Jayashree S Bhat, Sahikha Fahim, Ria Raju.   

Abstract

OBJECTIVES: Unilateral vocal fold paralysis (UVFP) occurs because of the dysfunction of the vagus nerve innervating the larynx. It causes a characteristic breathy voice often accompanied by swallowing disability, a weak cough, and the sensation of shortness of breath. Clinical evaluation of voice is generally based on perceptive criteria and the acoustic analysis of voice. In the present study, it is hypothesized that there would be an abnormal reduction of the cepstral peak in speakers with UVFP relative to the normal controls, as they are characterized by a breathy voice because of inadequate closure of vocal folds.
METHODS: Phonation of sustained vowel /a/ sample was subjected to acoustic analysis using Computerized Speech Lab (CSL model 4150; Kay Pentax, Lincoln Park, NJ) software. The vowels were analyzed acoustically by the measurement of cepstral peak prominence (CPP).
RESULTS: The results of 2 × 2 analysis of variance revealed the main effects of the groups (clinical vs control group), indicating reduced cepstral peak value in the clinical group in comparison with controls. The main effect of gender was also significant, indicating a decrease in the CPP value in the female group in comparison with the male group. The results obtained were discussed with respect to the underlying pathophysiology.
CONCLUSION: The present study investigated the CPP in subjects with UVFP. Cepstral deviations in the clinical group are explained to be the result of the presence of phonatory gap, leading to the lower values of CPP.
Copyright © 2011 The Voice Foundation. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20346619     DOI: 10.1016/j.jvoice.2009.12.010

Source DB:  PubMed          Journal:  J Voice        ISSN: 0892-1997            Impact factor:   2.009


  7 in total

1.  Relation of structural and vibratory kinematics of the vocal folds to two acoustic measures of breathy voice based on computational modeling.

Authors:  Robin A Samlan; Brad H Story
Journal:  J Speech Lang Hear Res       Date:  2011-04-15       Impact factor: 2.297

2.  Effect of Septoplasty on Cepstral Analysis of Voice.

Authors:  D Thejaswi; Rezwin M Alfred; Florida P D'Souza
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-05-29

3.  Relationship of cepstral analysis with voice self-assessments in dysphonic and normal speakers.

Authors:  Saeed Saeedi; Mahshid Aghajanzadeh; Seyyedeh Maryam Khoddami; Payman Dabirmoghaddam; Shohreh Jalaie
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-10-13       Impact factor: 3.236

4.  Cepstral analysis in patients with a vocal fold motility impairment: advantages of the cepstrum over time-based acoustic analysis.

Authors:  Beatriz Delgado-Vargas; Leticia Acle-Cervera; Lorena Sánz-López; Mireya Bonet-Loscertales; Narcisa Pérez-Naranjo; Patricia Fuentes-Navajo
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-08-24       Impact factor: 2.503

5.  Effects of Injection Laryngoplasty with Hyaluronic Acid in Patients with Vocal Fold Paralysis.

Authors:  Geun-Hyo Kim; Jae-Seok Lee; Chang-Yoon Lee; Yeon-Woo Lee; In-Ho Bae; Hee-June Park; Byung-Joo Lee; Soon-Bok Kwon
Journal:  Osong Public Health Res Perspect       Date:  2018-12

6.  Effect of Bhramari Pranayama on the Acoustic and Aerodynamic Parameters of Voice in Normophonic Females.

Authors:  Usha Manjunatha; Jayashree S Bhat; Kumar B Radish; Gagan Bajaj; Poovitha Shruthi; Priyanka Suresh Nayak; Saniya Mariam Rasheeka
Journal:  Evid Based Complement Alternat Med       Date:  2018-08-06       Impact factor: 2.629

7.  Impact of Subharmonic and Aperiodic Laryngeal Dynamics on the Phonatory Process Analyzed in Ex Vivo Rabbit Models.

Authors:  Fabian Thornton; Michael Döllinger; Stefan Kniesburges; David Berry; Christoph Alexiou; Anne Schützenberger
Journal:  Appl Sci (Basel)       Date:  2019-05-13       Impact factor: 2.679

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.